NCT03142659

Brief Summary

The investigator is trying to improving our knowledge in the treatment of HF patients, for the purpose of improving their quality of life and reducing hospitalizations. For achieving this the investigator would like to build a registry which will include all the HF patients going an evaluation in the Heart Failure unit or clinic in our facility,

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
5,000

participants targeted

Target at P75+ for all trials

Timeline
66mo left

Started Jul 2017

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress63%
Jul 2017Dec 2031

First Submitted

Initial submission to the registry

May 1, 2017

Completed
4 days until next milestone

First Posted

Study publicly available on registry

May 5, 2017

Completed
2 months until next milestone

Study Start

First participant enrolled

July 1, 2017

Completed
13.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2030

Expected
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2031

Last Updated

February 2, 2022

Status Verified

February 1, 2022

Enrollment Period

13.5 years

First QC Date

May 1, 2017

Last Update Submit

February 1, 2022

Conditions

Heart Failure

Outcome Measures

Primary Outcomes (2)

  • NP/ pro-BNP from baseline

    10 years

  • QT measurements

    ECG will be performed at baseline

    10 years

Interventions

registry-no interventionOTHER

registry-no intervention After filling the informed consent the patients will be evaluated for clinical history and physical examination by the nurse and a cardiologist. Then, the patients may perform the following test: ECG, Chest X-RAY, Blood test including: complete blood count, renal and liver function, electrolytes, thyroid function, cholesterol, glucose, Troponin and Brain Natriuretic Peptide

Eligibility Criteria

Age18 Years - 120 Years
Sexall
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Prospective registry which will include all the HF patients evaluated in the Heart Failure unit or clinic and will sign an informed consent form

You may qualify if:

  • Age ≥18 years old
  • Patient evaluated in the Heart Failure unit or clinic in our facility.
  • Approved consent.

You may not qualify if:

  • \. Patients who haven't signed the informed consent in the prospective group.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Tel Aviv Medical Center

Tel Aviv, Israel

RECRUITING

MeSH Terms

Conditions

Heart Failure

Condition Hierarchy (Ancestors)

Heart DiseasesCardiovascular Diseases

Study Officials

  • Michal Laufer Perl, MD

    Tel Aviv Medical Center

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Michal Laufer Perl, MD

CONTACT

972527360430michalpela@gmail.com

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
PROSPECTIVE
Target Duration
10 Years
Sponsor Type
OTHER GOV
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Head of Research and development

Study Record Dates

First Submitted

May 1, 2017

First Posted

May 5, 2017

Study Start

July 1, 2017

Primary Completion (Estimated)

December 31, 2030

Study Completion (Estimated)

December 31, 2031

Last Updated

February 2, 2022

Record last verified: 2022-02

Locations

IL(1)